The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variantsCoronVac 백신 3차 접종은 SARS-CoV-2 Delta 및 Omicron 변이체를 인식하는 광범위하고 강력한 적응 면역 반응 유도Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive Adaptive immune response B cell B cells boost booster booster dose booster vaccination CD4 CD8 Cell circulating comparable contagious CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine Delta demonstrated detectable domain dose effective elevated elicited fold follicular healthy subject helper T cell Humoral immunity IgA responses immune responses Inactivated vaccine individual induce memory B memory B cell memory B cells neutralization neutralization activities neutralization activity neutralizing activities omicron Omicron variants peaked predominant preserved Protein RBD receiving recognize reduced remained respiratory response SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 variant significantly increased spike-specific IgG strain subpopulations sustained T cell T cell responses T cells T cells response vaccination variant variants VOCs [DOI] 10.1080/22221751.2022.2081614 PMC 바로가기 [Article Type] Article
Humoral and cellular immune responses to CoronaVac up to one year after vaccinationArticle Published on 2022-10-212022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] all subject Antibody Response Antiviral CD4^{+} T cell cellular Cellular immune response cellular response clinical trial CoronaVac cytokine production cytokine profile defined effector memory evaluated follicular humoral Humoral response immune immune memory immune response impacted Inactivated vaccine individual induce memory Older peaked Phase 3 response SARS-CoV-2 SARS-CoV-2-specific IgG SARS-CoV-2-specific immune responses second dose sustained T cell activation T cell phenotype Tfh Th2 vaccination vaccine dose vaccinees [DOI] 10.3389/fimmu.2022.1032411 PMC 바로가기
Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination RegimesArticle Published on 2022-10-132022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accompanied antibody Antibody Response AstraZeneca B cell benefit booster vaccination cells Comparative courses COVID-19 COVID-19 pandemic Critical critical COVID-19 patients exceeded follicular Frequency Infection Inflammation Inflammatory response Johnson & Johnson long-COVID Lymphocytes Mild Moderna mRNA vaccine neutralizing antibody patients patients who survived Pfizer-BioNTech recommendation reduced regime SARS-CoV-2 SARS-CoV-2 patient severe COVID-19 disease the SARS-CoV-2 virus the Spike titer understanding vaccination Vaccination strategy Vaccine [DOI] 10.3390/ijms232012231 PMC 바로가기
Adaptive immunity to SARS-CoV-2 infection: A systematic reviewArticle Published on 2022-10-102022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 바이오마커, [키워드] acute respiratory syndrome adaptive Adaptive immunity addressed Alpha Antigen article B cell Biomarker case-control study caused CD4+ T cell CD8+ CD8+ T lymphocytes Cell cell types Characteristics clinical benefits Cohort studies coronavirus coronavirus disease Course COVID-19 Critically ill Critically ill patient cross-sectional CXCL9 Cytokines database disease English Evidence experimental evidence follicular HLA-DR humoral Humoral immunity IL-10 IL-13 IL-15 IL-17 IL-1α IL-2 IL-21 IL-22 IL-23 IL-4 IL-5 IL-7 immune system Immunity immunological Immunological memory immunopathological in vitro assays individuals inflammatory mediator involved leukocyte Ligand lymphocyte marker mild case Necrosis poor prognosis predominant produced programmed cell death progression Protein Regulatory T cell responsible SARS-CoV-2 SARS-COV-2 infection SciELO secretion severity Spanish subpopulation systematic review T helper T helper cell T lymphocyte T-cell Response Tfh TGF-β Th1 Th17 Th2 the antibody the disease TNF-α Treg tumor growth Vaccine variable [DOI] 10.3389/fimmu.2022.1001198 PMC 바로가기
NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responsesArticle Published on 2022-10-032022-11-15 Journal: The Journal of Clinical Investigation [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Adaptive immunity CD4+ CD4+ T cell CD4+ T cells CD8+ T cell Cell Cellular immune response characteristic characterization circulating correlated COVID-19 demonstrated detectable dose Efficacy follicular full-length SARS-CoV-2 functional humoral immune responses IFN-γ immune immunization immunology individual induce magnitude Matrix-M NVX-CoV2373 Protective Protein response responses robust SARS-CoV-2-neutralizing antibody spike trimer subset T cells Th1 cell trials vaccinated individual vaccination Vaccine [DOI] 10.1172/JCI160898 PMC 바로가기
Protein vaccine NVX-CoV2373 elicits functional T cell immunityArticle Published on 2022-10-032022-11-15 Journal: The Journal of Clinical Investigation [Category] COVID19(2023년), SARS, 진단, [키워드] Analysis Antibody Response association CD4+ CD4+ T cell CD8+ T cell Cell characterized circumvent dose Effect elicit elicited enrolled follicular functional humoral immune responses Immunity individual induce mRNA vaccine neutralizing antibody titers NVX-CoV2373 recognizing Region response robust SARS-CoV-2 antigen SARS-CoV-2 vaccine T cell T cell responses Trial Vaccine vaccine dose [DOI] 10.1172/JCI163614 PMC 바로가기
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concernArticle Published on 2022-09-292022-11-15 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, [키워드] addition AstraZeneca Beta booster booster dose CD4 CD4+ CD8+ central memory ChAdOx1 Concentration COVID-19 COVID-19 vaccine Delta evaluated follicular highest homologous IFN-gamma IgG IgG antibody IgG isotype IL-17 Immune escape immunogenic immunogenicity induce memory mice mice immunization neutralizing antibody Neutralizing antibody titer new SARS-CoV-2 performed Population populations Protein S protein SARS-CoV-2 SARS-CoV-2 S protein SARS-CoV-2 variant SARS-CoV-2 variants significantly higher spike trimer spike trimeric protein T cells tested trimeric Trimeric spike protein Vaccine vaccine candidate Vaccines variant variants viral variant virus viruses VoC Wuhan [DOI] 10.3389/fimmu.2022.1020159 PMC 바로가기
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell SarcomaSARS-CoV-2 환자에서 CD30 양성 여포 수지상 세포 증식이 풍부한 혈관면역모세포 T-세포 림프종: 관련 여포 수지상 세포 육종을 배제하기 위한 돌연변이 분석의 역할Case Reports Published on 2022-08-192022-09-11 Journal: International Journal of Molecular Sciences [Category] SARS, 바이오마커, 진단, [키워드] AITL angioimmunoblastic T-cell lymphoma CD30 CD30 expression defined dendritic cell differential diagnosis DNMT3A Exclude Exuberant follicular follicular dendritic cell proliferation. genetic analysis IDH2 involved lymphoma male Mutation proliferation reactive reported RHOA role Sarcoma SARS-CoV-2 SARS-COV-2 infection T-cell T-Cell Lymphoma TET2 [DOI] 10.3390/ijms23169349 PMC 바로가기 [Article Type] Case Reports
Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular LymphomaArticle Published on 2022-08-152022-11-15 Journal: Internal medicine (Tokyo, Japan) [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] anti-spike protein IgG Bendamustine coronavirus COVID-19 COVID-19 symptom COVID-19 symptoms detect Dexamethasone discharged exacerbated follicular Follicular lymphoma Immunocompromised Immunocompromised patient Immunocompromised patients lymphoma obinutuzumab obinutuzumab and bendamustine observation Patient Prolonged Prolonged COVID-19 Remdesivir SARS-CoV-2 vaccination subsequent Symptom the disease the patient treated [DOI] 10.2169/internalmedicine.9136-21 PMC 바로가기
T cell perturbations persist for at least 6 months following hospitalization for COVID-19T 세포 교란은 COVID-19로 입원한 후 최소 6개월 동안 지속됩니다.Article Published on 2022-08-082022-09-11 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료법, [키워드] addition affected alteration anti-Nucleocapsid IgG antibody Arm CD4 CD57 CD69 CD8 Cell consequence convalescence COVID-19 COVID-19 pathogenesis COVID-19 patient COVID-19 patients dependent on elevated event expressing flow cytometry follicular Hospitalization Humoral response humoral responses IgG immune immune cells immune system Immunity Inclusion marker Neutralizing Neutralizing antibodies neutralizing antibody responses Pathogenesis Perturbation Population populations SARS-CoV-2 spectral flow cytometry. study duration sustained symptom onset T cell T cell activation T cell impairment T cell responses T cell subsets T cells T helper TEMRA the disease upregulated with COVID-19 [DOI] 10.3389/fimmu.2022.931039 PMC 바로가기 [Article Type] Article